Adimab, Mersana to combine antibody technologies

Adimab LLC (Lebanon, N.H.) and Mersana Therapeutics Inc. (Cambridge, Mass.) partnered to offer integrated access to Adimab's yeast-based antibody discovery technology and Mersana's antibody-drug conjugate (ADC) platform. Mersana's ADC platform consists of the company's Fleximer polymer technology and customizable linkers for attaching payloads. Details were not disclosed. ...